Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
1.250
-0.020 (-1.57%)
At close: Nov 4, 2024, 4:00 PM
1.240
-0.010 (-0.80%)
After-hours: Nov 4, 2024, 7:28 PM EST
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$1,572,511
Market Cap
111.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
Karyopharm Therapeutics | 325 |
Rockwell Medical | 237 |
Veru Inc. | 189 |
Cibus | 183 |
Seer, Inc. | 147 |
Myomo | 106 |
Eupraxia Pharmaceuticals | 29 |
ALLK News
- 25 days ago - Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - GlobeNewsWire
- 3 months ago - Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - The Schall Law Firm Begins Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate - Accesswire
- 4 months ago - The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Engage - Accesswire
- 4 months ago - Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile - GlobeNewsWire
- 4 months ago - The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Join - Accesswire
- 4 months ago - The Schall Law Firm Starts Probe Into Claims Against Allakos Inc And Urges Affected Investors To Participate - Accesswire
- 4 months ago - The Schall Law Firm Initiates Investigation Into Allegations Against Allakos Inc And Encourages Impacted Investors To Get Involved - Accesswire